Registro y análisis de datos demográficos,clínicos y de respuesta a tratamiento en pacientes con trastornos del movimiento.

Datos básicos

Código:
2022-130-1_EOm
Protocolo:
2022-130-1_EOm
EUDRACT:
NCT:
Centro:
HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
Dotación:
Año de incio:
2022
Año de finalización:
2027
ESTUDIO OBSERVACIONAL

Documentos

  • No hay documentos

Participantes

Grupos

Financiadores - Promotores

IRENE MARTÍNEZ TORRES

Resultados del Ensayo Clínico


Artificial intelligence for identification of candidates for device-aided therapy in Parkinson's disease: DELIST-PD study.

Freire-Alvarez, Eric; (...); Escamilla-Sevilla, Francisco

Article. 10.1016/j.compbiomed.2024.109504. 2024


Diagnostic Efficacy of Genetic Studies in a Series of Hereditary Cerebellar Ataxias in Eastern Spain.

Baviera-Munoz, Raquel; (...); Aller, Elena

Article. 10.1212/NXG.0000000000200038. 2022


Efectos adversos y complicaciones de la infusión intestinal continua de levodopa-carbidopa en una cohorte de pacientes con enfermedad de Parkinson de un hospital terciario.

Campins-Romeu, Marina; (...); Martinez-Torres, Irene

Article. 10.33588/rn.7405.2021482. 2022


Effectiveness and safety of levodopa-entacapone-carbidopa infusion in Parkinson disease: A real-world data study.

Santos-García D; (...); Mata M

Article. 10.1111/ene.16535. 2024


Estimulación cerebral profunda combinada del núcleo subtalámico y el globo pálido interno en la enfermedad de Parkinson.

Campins-Romeu M; (...); Martínez-Torres I

Case Reports. 10.33588/rn.7703.2022250. 2023


Gait Function after High-Intensity Focused Ultrasound Thalamotomy for Essential Tremor: Searching for Technique Optimization.

Sastre-Bataller, Isabel; (...); Martinez-Torres, Irene

Article. 10.1159/000527374. 2023


Health-Related Quality of Life in Patients Living with Wilson Disease in Spain: A Cross-Sectional Observational Study.

Marino, Zoe; (...); Anguera, Anna

Article. 10.3390/jcm12144823. 2023


MRgFUS subthalamotomy in Parkinson's disease: an approach aimed at minimizing Lesion Volume

Campins-Romeu, Marina; (...); Martinez-Torres, Irene

Article. 10.1038/s41531-024-00843-7. 2024


MRgFUS subthalamotomy in Parkinson's disease: an approach aimed at minimizing Lesion Volume (vol 10, 230, 2024)

Campins-Romeu, Marina; (...); Martinez-Torres, Irene

Correction. 10.1038/s41531-025-00871-x. 2025

  • Open Access.

Mutations, genes and phenotypes related to movement disorders: a never-ending list

Martinez-Rubio, Dolores; (...); Espinos, Carmen

Meeting Abstract. 2022


Profile of plasma microRNAs as a potential biomarker of Wilson's disease.

Sanchez-Monteagudo, Ana; (...); Espinos, Carmen

Article. 10.1007/s00535-024-02135-6. 2024


Refractory status epilepticus due to vitamin B6 deficit in a Parkinson's disease patient in treatment with levodopa/carbidopa intestinal gel

Baviera-Munoz, R.; (...); Martinez-Torres, I.

Letter. 10.1016/j.nrl.2021.10.002. 2022


Refractory status epilepticus due to vitamin B6 deficit in a Parkinson's disease patient in treatment with levodopa/carbidopa intestinal gel.

Baviera-Muñoz R; (...); Martinez-Torres I

Article. 10.1016/j.nrleng.2021.10.002. 2022


Smoking is associated with age at disease onset in Parkinson's disease.

Rosas I; (...); Bandrés-Ciga S

Article. 10.1016/j.parkreldis.2022.03.005. 2022


Spinocerebellar Ataxia 36 is a Frequent Cause of Hereditary Ataxia in Eastern Spain

Baviera-Munoz, Raquel; (...); Bataller, Luis

Article. 10.1002/mdc3.13740. 2023


Staging Parkinson's Disease According to the MNCD (Motor/Non-motor/Cognition/Dependency) Classification Correlates with Disease Severity and Quality of Life.

Santos-Garcia, Diego; (...); Mir, Pablo

Article. 10.3233/JPD-225073. 2023


STUB1 Mutations as Possible Genetic Modifiers in Spinocerebellar Ataxia Type 8.

Baviera-Munoz, Raquel; (...); Aller, Elena

Article. 10.1002/mds.29910. 2024


Unilateral MRIgFUS thalamotomy: Long-term follow-up in fragile X-associated tremor/ataxia syndrome.

Campins-Romeu M; (...); Sastre-Bataller I

Case Reports. 10.1016/j.nrleng.2024.09.004. 2024


Use of the MNCD Classification to Monitor Clinical Stage and Response to Levodopa-Entacapone-Carbidopa Intestinal Gel Infusion in Advanced Parkinson's Disease

Santos-Garcia, Diego; (...); Alvarez-Santullano, Marina Mata

Article. 10.3390/brainsci14121244. 2024


Campos de estudio

Compartir